Literature DB >> 33466491

Determination of Intraprostatic and Intratesticular Androgens.

Markéta Šimková1,2, Jiří Heráček3,4, Pavel Drašar2, Richard Hampl1.   

Abstract

Androgens represent the main hormones responsible for maintaining hormonal balance and function in the prostate and testis. As they are involved in prostate and testicular carcinogenesis, more detailed information of their active concentration at the site of action is required. Since the introduction of the term intracrinology as the local formation of active steroid hormones from inactive precursors of the adrenal gland, mainly dehydroepiandrosterone (DHEA) and DHEA-S, it is evident that blood circulating levels of sex steroid hormones need not reflect their actual concentrations in the tissue. Here, we review and critically evaluate available methods for the analysis of human intraprostatic and intratesticular steroid concentrations. Since analytical approaches have much in common in both tissues, we discuss them together. Preanalytical steps, including various techniques for separation of the analytes, are compared, followed by the end-point measurement. Advantages and disadvantages of chromatography-mass spectrometry (LC-MS, GC-MS), immunoanalytical methods (IA), and hybrid (LC-IA) are discussed. Finally, the clinical information value of the determined steroid hormones is evaluated concerning differentiating between patients with cancer or benign hyperplasia and between patients with different degrees of infertility. Adrenal-derived 11-oxygenated androgens are mentioned as perspective prognostic markers for these purposes.

Entities:  

Keywords:  androgens; biomarkers; cancer; determination; disease prediction; methods; prostate; testes

Mesh:

Substances:

Year:  2021        PMID: 33466491      PMCID: PMC7796479          DOI: 10.3390/ijms22010466

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  75 in total

1.  Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.

Authors:  Andrea D Coviello; Alvin M Matsumoto; William J Bremner; Karen L Herbst; John K Amory; Bradley D Anawalt; Paul R Sutton; William W Wright; Terry R Brown; Xiaohua Yan; Barry R Zirkin; Jonathan P Jarow
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

2.  Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.

Authors:  Mark A Titus; Michael J Schell; Fred B Lih; Kenneth B Tomer; James L Mohler
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

3.  Simultaneous analysis by LC-MS/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue.

Authors:  Merja R Häkkinen; Teemu Murtola; Raimo Voutilainen; Matti Poutanen; Tero Linnanen; Johanna Koskivuori; Timo Lakka; Jarmo Jääskeläinen; Seppo Auriola
Journal:  J Pharm Biomed Anal       Date:  2018-11-16       Impact factor: 3.935

4.  Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?

Authors:  M Šimková; J Vítků; L Kolátorová; J Vrbíková; M Vosátková; J Včelák; M Dušková
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

5.  Targeted androgen pathway suppression in localized prostate cancer: a pilot study.

Authors:  Elahe A Mostaghel; Peter S Nelson; Paul Lange; Daniel W Lin; Mary Ellen Taplin; Steven Balk; William Ellis; Philip Kantoff; Brett Marck; Daniel Tamae; Alvin M Matsumoto; Lawrence D True; Robert Vessella; Trevor Penning; Rachel Hunter Merrill; Roman Gulati; Bruce Montgomery
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

6.  Prostatic carcinoma: plasma kinetics and intraprostatic metabolism of testosterone in low-dose estrogen-treated patients in vivo.

Authors:  G H Jacobi; K Sinterhauf; J E Altwein
Journal:  Urology       Date:  1978-09       Impact factor: 2.649

Review 7.  The role of adrenal derived androgens in castration resistant prostate cancer.

Authors:  Monique Barnard; Elahe A Mostaghel; Richard J Auchus; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-10-28       Impact factor: 4.292

Review 8.  Steroidogenesis of the testis -- new genes and pathways.

Authors:  Christa E Flück; Amit V Pandey
Journal:  Ann Endocrinol (Paris)       Date:  2014-04-29       Impact factor: 2.478

9.  High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.

Authors:  Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Satoshi Morita; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota
Journal:  BMC Cancer       Date:  2014-09-26       Impact factor: 4.430

Review 10.  11β-hydroxyandrostenedione returns to the steroid arena: biosynthesis, metabolism and function.

Authors:  Liezl M Bloem; Karl-Heinz Storbeck; Lindie Schloms; Amanda C Swart
Journal:  Molecules       Date:  2013-10-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.